# Andson Biotech Inc. — Form D

Andson Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-22. The offering totals $5.0M, of which $4.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-10-22
- Form: D
- Accession: 0002017131-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.7M
- Remaining: $265K
- Investors: 29
- Date of first sale: 2025-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561640

## Issuer

- Name: Andson Biotech Inc.
- CIK: 0002017131
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1705 COMMERCE DR NW, ATLANTA, GA, 30318
- Phone: 7273897725

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Mason Chilmonczyk | Director | Atlanta, GA |
| Glenn Epstein | Director | Atlanta, GA |
| Andrei Fedorov | Director | Atlanta, GA |
| Thomas O'Brien | Director | Jersey City, NJ |
| James Ross | Director | Metairie, LA |
| Mason Chilmonczyk | Executive Officer | Atlanta, GA |
| Jim Filippini | Executive Officer | Atlanta, GA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-03-26](https://search.stillhousedata.com/formd/0002017131-24-000001) | D | $3.6M | $3.6M |

## More

- [CIK 2017131 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2017131&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002017131-25-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.